|
ADNP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.044500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.673600E-02 |
| Normal-vs-Stage2 |
1.236230E-03 |
| Normal-vs-Stage3 |
1.74803999999362E-05 |
| Normal-vs-Stage4 |
7.97780000000303E-05 |
| Stage1-vs-Stage2 |
1.049960E-01 |
| Stage1-vs-Stage3 |
2.303000E-03 |
| Stage1-vs-Stage4 |
8.863200E-03 |
| Stage2-vs-Stage3 |
5.297400E-01 |
| Stage2-vs-Stage4 |
5.720800E-01 |
| Stage3-vs-Stage4 |
9.904800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.046700E-04 |
| Normal-vs-AfricanAmerican |
5.953700E-04 |
| Normal-vs-Asian |
9.702000E-01 |
| Caucasian-vs-AfricanAmerican |
2.579800E-01 |
| Caucasian-vs-Asian |
2.325400E-01 |
| AfricanAmerican-vs-Asian |
1.433350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.41489999999578E-05 |
| Normal-vs-Female |
3.042500E-03 |
| Male-vs-Female |
3.404200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.183800E-02 |
| Normal-vs-Age(41-60Yrs) |
5.175700E-03 |
| Normal-vs-Age(61-80Yrs) |
4.404900E-04 |
| Normal-vs-Age(81-100Yrs) |
3.71929999998244E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.791000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.415800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.893900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.690200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.639600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.297500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.052800E-01 |
| Normal-vs-Grade 2 |
4.782200E-02 |
| Normal-vs-Grade 3 |
4.3054999999681E-06 |
| Normal-vs-Grade 4 |
2.70520000000829E-06 |
| Grade 1-vs-Grade 2 |
2.918000E-01 |
| Grade 1-vs-Grade 3 |
2.154100E-02 |
| Grade 1-vs-Grade 4 |
1.162040E-02 |
| Grade 2-vs-Grade 3 |
1.039880E-03 |
| Grade 2-vs-Grade 4 |
4.555100E-04 |
| Grade 3-vs-Grade 4 |
1.989800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.383700E-02 |
| Normal-vs-ccB subtype |
1.201220E-03 |
| ccA subtype-vs-ccB subtype |
3.123800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.204320E-03 |
| Normal-vs-N1 |
2.310200E-01 |
| N0-vs-N1 |
9.961400E-01 |
|
|
